-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
io" style="margin-top:0px;margin-bottom:10px;padding:0px;max-width:100%;clear:both;min-height:1em;letter-spacing:0.
5px;">
5px;">No matter how good a car is, it can't do anything without fuel/electricity.
5px;">And accessing such data can be challenging.
5px;">Recently, Madlaina Costa-Scharplatz, Head of Real World Evidence for Novartis Nordic Region, Peter Hovstadius, Chief Innovation Officer of Novartis Nordic Region, and Jacob LaPorte, Global Head of Novartis Biome, introduced some of the Nordic experience through an opinion article published on STAT.
5px;">They said that for more than half a century, these countries (Denmark, Finland, Iceland, Norway, and Sweden) have been building a strong data base to help unlock the promise of AI and accelerate the development of personalized medicine on a global scale.
5px;">With such a model, patients can have their own data and at the same time license the data to the national machine learning ecosystem for analysis.
While the data is in the hands of the patient, it provides information for a complex and powerful collection, the best of both worlds.